Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
When preventable infections turn deadly behind bars | The Excerpt - 2SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- 3Dick Van Dyke shares his secrets to longevity as he turns 100
- 4World leaders, rights groups react to COP30 climate deal
- 5Extraordinary Shows to Long distance race on a Plane
- 10 Hints for an Effective New employee screening
- Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- Why are malnutrition deaths soaring in America?
- 5 Most Expected Film Delivery
- 6 U.S. States for Climbing
- NASA says Maven spacecraft that was orbiting Mars has gone silent
- Hubble Space Telescope spies dusty debris from two cosmic collisions
- 6 Arranging Administrations to Change Your Open air Space
- Most loved Occasion Dish: What Makes Your Merry Table?
